Page 6 - Dcph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) released its earnings results on Wednesday. The company reported ($0.57) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.62) by $0.05, Briefing.com reports. Deciphera Pharmaceuticals had a negative net margin of 129.90% and a negative return on equity of 47.99%. The company had revenue […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price was down 3.9% on Monday . The stock traded as low as $13.16 and last traded at $13.18. 40,322 shares traded hands during trading, a decline of 94% from the average daily volume of 669,164 shares. The stock had previously closed at $13.71. Analysts Set […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 30th, there was short interest totalling 3,790,000 shares, a drop of 14.1% from the June 15th total of 4,410,000 shares. Based on an average daily trading volume, of 533,300 […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 4,310,000 shares, an increase of 14.9% from the May 15th total of 3,750,000 shares. Based on an average daily volume of 622,700 shares, the […]

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Rating) and ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability. Institutional & Insider Ownership 72.7% of Deciphera Pharmaceuticals shares […]